HUMAN CELL MODELS--LONGTERM LOW DOSE EXPOSURES AND MUTANT RESISTANT STATE
人体细胞模型——长期低剂量暴露和突变抵抗状态
基本信息
- 批准号:6338776
- 负责人:
- 金额:$ 22.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-08-03 至 2003-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We have discovered that when our human cell line, AHH-1, which expresses
cytochrome P-450 1A1, is exposed continuously to low concentrations of
potent airborne mutagens such as benzo(a)pyrene and naphtho(a)pyrene that
they switch from a high mutation rate to a low mutation rate after 5 days.
This low mutations rate is only some three fold higher than seen for
spontaneous mutation in the concurrent untreated controls. Studies with
radioactive benzo(a)pyrene show that the rate of DNA adduct formation is
unchanged by this phenomenon. The ratio of the rate of mutation relative
to the rate of constant DNA adduction is changed by a factor of four
suggesting induction of a post-DNA adduction process such as DNA repair is
occurring.
Because such a phenomenon would, if occurring in vivo, represent a major
physiologic response protecting against induction of mutations by airborne
toxicants. Our studies so far establish that the induction of the
mutation-resistance by benzo(a)pyrene confers cross-resistance to mutation
by the potent airborne mutagen, cyclopenta[c,d]pyrene. Secondly, we have
found that another potent airborne mutagen naphtho(a)pyrene induces
resistance to mutation in a time dependent pattern similar to that of
benzo(a)pyrene. Finally, we have found human cell lines derived from AHH-1
which are markedly sensitive to mutation by air sample extract under short
term high dose conditions giving use a useful mode for proposed long term
dose mimicking conditions of samples, source samples and their extracts
and subfractions on these human cells under these long term low dose
conditions which more closely approximate the conditions of exposure in
the human bronciolar tree, (b) discover it the "mutation resistant state"
is induced by exposure to raw air particulates, by particulate extracts
and by particulate extract subfractions, and (c.) carry out appropriate
studies of the process at the cellular and molecular levels.
我们发现,当我们的人类细胞系 AHH-1 表达
细胞色素 P-450 1A1,连续暴露于低浓度
强效空气诱变剂,例如苯并(a)芘和萘并(a)芘
5 天后,它们从高突变率转变为低突变率。
这种低突变率仅比所见的高三倍左右
同时未治疗的对照中发生自发突变。研究与
放射性苯并(a)芘表明DNA加合物形成的速率为
这种现象没有改变。相对突变率之比
恒定 DNA 加合速率改变了四倍
表明 DNA 加合后过程(例如 DNA 修复)的诱导是
发生。
因为这种现象如果发生在体内,将代表一个重大的
防止空气传播诱发突变的生理反应
有毒物质。到目前为止,我们的研究表明,诱导
苯并(a)芘的突变抗性赋予对突变的交叉抗性
由强效空气诱变剂环戊[c,d]芘引起。其次,我们有
发现另一种有效的空气诱变剂萘并(a)芘诱导
以类似于时间依赖模式的突变抵抗力
苯并(a)芘。最后,我们找到了源自AHH-1的人类细胞系
对短时间下空气样本提取物的突变非常敏感
长期高剂量条件为建议的长期使用提供了有用的模式
样品、源样品及其提取物的剂量模拟条件
以及在这些长期低剂量下对这些人体细胞的亚组分
更接近暴露条件的条件
人类细支气管树,(b) 发现它的“突变抵抗状态”
是由暴露于原始空气颗粒物、颗粒提取物引起的
和通过颗粒提取物亚级分,并且(c.)进行适当的
在细胞和分子水平上研究该过程。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William G Thilly其他文献
Analysis of mutational spectra by denaturing capillary electrophoresis
通过变性毛细管电泳分析突变谱
- DOI:
10.1038/nprot.2008.79 - 发表时间:
2008-06-19 - 期刊:
- 影响因子:16.000
- 作者:
Per O Ekstrøm;Konstantin Khrapko;Xiao-Cheng Li-Sucholeiki;Ian W Hunter;William G Thilly - 通讯作者:
William G Thilly
William G Thilly的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William G Thilly', 18)}}的其他基金
ANALYSIS OF LUNG CANCER MORTALITY RECORDS/DEVELOP QUANTITATIVE WORKING MODEL
分析肺癌死亡率记录/开发定量工作模型
- 批准号:
6338779 - 财政年份:2000
- 资助金额:
$ 22.21万 - 项目类别:
HUMAN PERIPHERAL BLOOD STUDIES OF MUTATIONS IN THE ABERJONA REGION
阿伯霍纳地区的人类外周血突变研究
- 批准号:
6106147 - 财政年份:1999
- 资助金额:
$ 22.21万 - 项目类别:
HUMAN PERIPHERAL BLOOD STUDIES OF MUTATIONS IN THE ABERJONA REGION
阿伯霍纳地区的人类外周血突变研究
- 批准号:
6340899 - 财政年份:1999
- 资助金额:
$ 22.21万 - 项目类别:
HUMAN CELL MODELS--LONGTERM LOW DOSE EXPOSURES AND MUTANT RESISTANT STATE
人体细胞模型——长期低剂量暴露和突变抵抗状态
- 批准号:
6106413 - 财政年份:1999
- 资助金额:
$ 22.21万 - 项目类别:
ANALYSIS OF LUNG CANCER MORTALITY RECORDS/DEVELOP QUANTITATIVE WORKING MODEL
分析肺癌死亡率记录/开发定量工作模型
- 批准号:
6106416 - 财政年份:1999
- 资助金额:
$ 22.21万 - 项目类别:
HUMAN CELL CULTURE STUDIES OF MUTAGENS IN THE ABERJONA BASIN
阿伯霍纳盆地诱变剂的人类细胞培养研究
- 批准号:
6340888 - 财政年份:1999
- 资助金额:
$ 22.21万 - 项目类别:
HUMAN CELL CULTURE STUDIES OF MUTAGENS IN THE ABERJONA BASIN
阿伯霍纳盆地诱变剂的人类细胞培养研究
- 批准号:
6106136 - 财政年份:1999
- 资助金额:
$ 22.21万 - 项目类别:
相似海外基金
DNA repair pathway coordination during damage processing
损伤处理过程中 DNA 修复途径的协调
- 批准号:
10748479 - 财政年份:2024
- 资助金额:
$ 22.21万 - 项目类别:
CAREER: Mechanisms and consequences of epigenome-recruited DNA repair systems in plants
职业:植物中表观基因组招募的 DNA 修复系统的机制和后果
- 批准号:
2338236 - 财政年份:2024
- 资助金额:
$ 22.21万 - 项目类别:
Continuing Grant
Elucidation of the molecular link between DNA repair and mitochondrial nucleic acid metabolism
阐明DNA修复和线粒体核酸代谢之间的分子联系
- 批准号:
23K07078 - 财政年份:2023
- 资助金额:
$ 22.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Biochemistry of Eukaryotic Replication Fork and DNA Repair
真核复制叉的生物化学和 DNA 修复
- 批准号:
10550045 - 财政年份:2023
- 资助金额:
$ 22.21万 - 项目类别:
Structural studies for understanding the mechanism of DNA repair in chromatin
了解染色质 DNA 修复机制的结构研究
- 批准号:
23H05475 - 财政年份:2023
- 资助金额:
$ 22.21万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Multifaceted regulation of the DNA repair machinery and suppression of aberrant transcription by telomere proteins
DNA 修复机制的多方面调控和端粒蛋白异常转录的抑制
- 批准号:
2246561 - 财政年份:2023
- 资助金额:
$ 22.21万 - 项目类别:
Standard Grant
A role of balanced sex hormone in DNA repair in human melanocytes
平衡性激素在人类黑素细胞 DNA 修复中的作用
- 批准号:
10666307 - 财政年份:2023
- 资助金额:
$ 22.21万 - 项目类别:
Natural products inhibitors targeting homology-directed DNA repair for cancer therapy
针对癌症治疗的同源定向 DNA 修复的天然产物抑制剂
- 批准号:
10651048 - 财政年份:2023
- 资助金额:
$ 22.21万 - 项目类别:
Modeling the Responsiveness of Sensitive Populations to Genotoxic Agents Using DNA Repair Inhibitors
使用 DNA 修复抑制剂模拟敏感人群对基因毒性药物的反应性
- 批准号:
10734425 - 财政年份:2023
- 资助金额:
$ 22.21万 - 项目类别: